儿童急性淋巴细胞白血病中天冬酰胺酶活性水平与毒性的关联:NOPHO ALL2008研究
该研究纳入1155例1.0至17.9岁、2008年7月至2016年3月确诊并按NOPHO ALL2008方案治疗的儿童ALL患者,分析天冬酰胺酶酶活性(AEA)水平与天冬酰胺酶相关毒性(AspTox)风险的关系。采用时间依赖多变量Cox模型调整性别和年龄后发现,总体AspTox及复发风险与AEA水平无关,但胰腺炎和骨坏死风险随AEA水平升高而增加。
核心结论
- 总体AspTox和复发与AEA水平无关,但胰腺炎和骨坏死风险随AEA水平升高而增加。
研究设计与样本
- 研究纳入1155例1.0至17.9岁、2008年7月至2016年3月确诊的儿童ALL患者,均按NOPHO ALL2008方案治疗。
- 纳入标准为至少2次天冬酰胺酶给药后14±2天采集的AEA血样,共6944个 trough 值。
- 采用时间依赖多变量Cox模型分析首次AspTox时间,调整性别和年龄。
主要发现
- 955例患者AEA可测(>0 IU/L),200例(17.3%)出现天冬酰胺酶失活且AspTox记录较少。
临床怎么用
- 监测AEA水平可能有助于识别胰腺炎和骨坏死风险较高的儿童ALL患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Asparaginase treatment is a mainstay in contemporary treatment of acute lymphoblastic leukemia (ALL), but substantial asparaginase-related toxicity may lead to jeopardized protocol compliance and compromises survival. We investigated the association between risk of asparaginase-associated toxicities (AspTox) and asparaginase enzyme activity (AEA) levels in 1155 children aged 1.0 to 17.9 years, diagnosed with ALL between July 2008 and March 2016, and treated according to the Nordic Society of Pediatric Hematology and Oncology (NOPHO) ALL2008 protocol. Patients with ≥2 blood samples for AEA measurement drawn 14 ± 2 days after asparaginase administration were included (6944 trough values). AEA was measurable (or >0 IU/L) in 955 patients, whereas 200 patients (17.3%) had asparaginase inactivation and few AspTox recorded. A time-dependent multiple Cox model of time to any first asparaginase-associated toxicity adjusted for sex and age was used. For patients with measurable AEA, we found a hazard ratio (HR) of 1.17 per 100 IU/L increase in median AEA (95% confidence interval [CI], 0.98-1.41; P = .09). For pancreatitis, thromboembolism, and osteonecrosis, the HRs were 1.40 (95% CI, 1.12-1.75; P = .002), 0.99 (95% CI, 0.70-1.40; P = .96), and 1.36 (95% CI, 1.04-1.77; P = .02) per 100 IU/L increase in median AEA, respectively. No significant decrease in the risk of leukemic relapse was found: HR 0.88 per 100 IU/L increase in AEA (95% CI, 0.66-1.16; P = .35). In conclusion, these results emphasize that overall AspTox and relapse are not associated with AEA levels, yet the risk of pancreatitis and osteonecrosis increases with increasing AEA levels.
引用
- Lynggaard LS, Rank CU, Hansen SN, et al. Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 study. Blood Adv. 2022. PMID: 34625787. doi:10.1182/bloodadvances.2021005631
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。